Weijer Ruud, Broekgaarden Mans, van Golen Rowan F, Bulle Esther, Nieuwenhuis Esther, Jongejan Aldo, Moerland Perry D, van Kampen Antoine H C, van Gulik Thomas M, Heger Michal
Department of Experimental Surgery, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.
Bioinformatics Laboratory, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105, AZ, Amsterdam, The Netherlands.
BMC Cancer. 2015 Dec 26;15:1014. doi: 10.1186/s12885-015-1994-2.
Photodynamic therapy (PDT) of solid cancers comprises the administration of a photosensitizer followed by illumination of the photosensitizer-replete tumor with laser light. This induces a state of local oxidative stress, culminating in the destruction of tumor tissue and microvasculature and induction of an anti-tumor immune response. However, some tumor types, including perihilar cholangiocarcinoma, are relatively refractory to PDT, which may be attributable to the activation of survival pathways in tumor cells following PDT (i.e., activator protein 1 (AP-1)-, nuclear factor of kappa light polypeptide gene enhancer in B-cells (NF-κB)-, hypoxia-inducible factor 1-alpha (HIF-1α)-, nuclear factor (erythroid-derived 2)-like 2 (NFE2L2)-, and unfolded protein response-mediated pathways).
To assess the activation of survival pathways after PDT, human perihilar cholangiocarcinoma (SK-ChA-1) cells were subjected to PDT with zinc phthalocyanine (ZnPC)-encapsulating liposomes. Following 30-minute incubation with liposomes, the cells were either left untreated or treated at low (50 mW) or high (500 mW) laser power (cumulative light dose of 15 J/cm(2)). Cells were harvested 90 min post-PDT and whole genome expression analysis was performed using Illumina HumanHT-12 v4 expression beadchips. The data were interpreted in the context of the survival pathways. In addition, the safety of ZnPC-encapsulating liposomes was tested both in vitro and in vivo.
PDT-treated SK-ChA-1 cells exhibited activation of the hypoxia-induced stress response via HIF-1α and initiation of the pro-inflammatory response via NF-кB. PDT at low laser power in particular caused extensive survival signaling, as evidenced by the significant upregulation of HIF-1- (P < 0.001) and NF-кB-related (P < 0.001) genes. Low-power PDT was less lethal to SK-ChA-1 cells 90 min post-PDT, confirmed by annexin V/propidium iodide staining. In vitro toxicogenomics and toxicological testing in chicken embryos and mice revealed that the ZnPC-encapsulating liposomes are non-toxic.
PDT-treated perihilar cholangiocarcinoma cells exhibit extensive survival signaling that may translate to a suboptimal therapeutic response and possibly tumor recurrence. These findings encourage the development of photosensitizer delivery systems with co-encapsulated inhibitors of survival pathways.
实体癌的光动力疗法(PDT)包括给予光敏剂,随后用激光照射富含光敏剂的肿瘤。这会诱导局部氧化应激状态,最终导致肿瘤组织和微血管的破坏,并诱导抗肿瘤免疫反应。然而,一些肿瘤类型,包括肝门周围胆管癌,对PDT相对难治,这可能归因于PDT后肿瘤细胞中生存途径的激活(即激活蛋白1(AP-1)、B细胞中κ轻链多肽基因增强子的核因子(NF-κB)、缺氧诱导因子1α(HIF-1α)、核因子(红系衍生2)样2(NFE2L2)和未折叠蛋白反应介导的途径)。
为了评估PDT后生存途径的激活情况,将人肝门周围胆管癌(SK-ChA-1)细胞用包裹锌酞菁(ZnPC)的脂质体进行PDT处理。与脂质体孵育30分钟后,细胞要么不进行处理,要么用低(50 mW)或高(500 mW)激光功率处理(累积光剂量为15 J/cm²)。在PDT后90分钟收获细胞,并使用Illumina HumanHT-12 v4表达微珠芯片进行全基因组表达分析。数据在生存途径的背景下进行解释。此外,还在体外和体内测试了包裹ZnPC的脂质体的安全性。
经PDT处理的SK-ChA-1细胞通过HIF-1α表现出缺氧诱导应激反应的激活,并通过NF-κB引发促炎反应。特别是低激光功率的PDT导致广泛的生存信号传导,HIF-1相关基因(P < 0.001)和NF-κB相关基因(P < 0.001)的显著上调证明了这一点。通过膜联蛋白V/碘化丙啶染色证实,低功率PDT在PDT后90分钟对SK-ChA-1细胞的致死性较低。在鸡胚和小鼠中进行的体外毒理基因组学和毒理学测试表明,包裹ZnPC的脂质体无毒。
经PDT处理的肝门周围胆管癌细胞表现出广泛的生存信号传导,这可能转化为次优的治疗反应并可能导致肿瘤复发。这些发现鼓励开发共包裹生存途径抑制剂的光敏剂递送系统。